CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) was the target of a large decline in short interest during the month of April. As of April 30th, there was short interest totaling 19,064 shares, a decline of 39.2% from the April 15th total of 31,352 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 140,854 shares, the short-interest ratio is presently 0.1 days.
CochLear Stock Performance
Shares of CHEOY stock opened at $34.40 on Monday. CochLear has a 52-week low of $31.82 and a 52-week high of $105.60. The stock has a fifty day simple moving average of $52.47 and a two-hundred day simple moving average of $74.82.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on CHEOY. Royal Bank Of Canada raised shares of CochLear from a “hold” rating to a “moderate buy” rating in a research report on Monday, January 19th. UBS Group lowered shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. Finally, Zacks Research upgraded CochLear to a “hold” rating in a research note on Friday, April 17th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, CochLear presently has an average rating of “Moderate Buy”.
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Featured Stories
- Five stocks we like better than CochLear
- As U.S. Debt Surpasses GDP, These 2 ETFs Are Emerging Winners in the “Sell America” Trade
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
